What challenges do local pharmaceutical manufacturers face in complying with regulations from the World Health Organisation (WHO)?
What challenges do local pharmaceutical manufacturers face in complying with regulations from the World Health Organisation (WHO)?
With almost half of all Nigerians living below the poverty line and facing the dual burden of a high incidence of both infectious and non-communicable diseases (NCDs), Nigeria’s under-funded public health system is under immense pressure. Accordingly, international aid organisations and the private sector have a significant role to play in alleviating the burden on the...
With almost half of all Nigerians living below the poverty line and facing the dual burden of a high incidence of both infectious and non-communicable diseases (NCDs), Nigeria’s under-funded public health system is under significant pressure. Accordingly, international aid organisations and the private sector have a major role to play in alleviating the burden on the state, and there is a...
Fresh from a rebasing exercise in April 2014 that boosted 2013 GDP by 89% to $509.97bn, Nigeria now ranks not only as Africa’s most populous country, but also as its largest economy. It has long played an outsized regional role, making up 76% of West Africa’s GDP and around 60% of its population.
With a new federal health bill in the works and steadily increasing private sector participation in many areas, Nigeria’s health care sector is potentially on the brink of a period of sustained expansion. In the six decades since independence, the national health care network has improved on a piecemeal basis, driven primarily by a handful of...
With a population of around 168.8m, and low levels of government spending on health care across the board, the provision of health services in Nigeria is defined by a series of challenges and constraints. The public network of health-related facilities, which includes clinics and hospitals at the community, state and federal levels, has been...
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×